Search Page

1

Cite

Share

Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.

Ahlawat S, Fayad LM, Khan MS, Bredella MA, Harris GJ, Evans DG, Farschtschi S, Jacobs MA, Chhabra A, Salamon JM, Wenzel R, Mautner VF, Dombi E, Cai W, Plotkin SR, Blakeley JO; Whole Body MRI Committee for the REiNS International Collaboration; REiNS International Collaboration Members 2016. Ahlawat S, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S31-9. doi: 10.1212/WNL.0000000000002929. Neurology. 2016. PMID: 27527647 Free PMC article.

Cite

Share

2

Cite

Share

Current status and recommendations for biomarkers and biobanking in neurofibromatosis.

Hanemann CO, Blakeley JO, Nunes FP, Robertson K, Stemmer-Rachamimov A, Mautner V, Kurtz A, Ferguson M, Widemann BC, Evans DG, Ferner R, Carroll SL, Korf B, Wolkenstein P, Knight P, Plotkin SR; REiNS International Collaboration. Hanemann CO, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S40-8. doi: 10.1212/WNL.0000000000002932. Neurology. 2016. PMID: 27527649 Free PMC article.

Cite

Share

3

Cite

Share

Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.

Wolters PL, Martin S, Merker VL, Tonsgard JH, Solomon SE, Baldwin A, Bergner AL, Walsh K, Thompson HL, Gardner KL, Hingtgen CM, Schorry E, Dudley WN, Franklin B; REiNS International Collaboration. Wolters PL, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S4-S12. doi: 10.1212/WNL.0000000000002927. Neurology. 2016. PMID: 27527648 Free PMC article.

Cite

Share

4

Cite

Share

Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1.

Plotkin SR, Davis SD, Robertson KA, Akshintala S, Allen J, Fisher MJ, Blakeley JO, Widemann BC, Ferner RE, Marcus CL; REiNS International Collaboration. Plotkin SR, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S13-20. doi: 10.1212/WNL.0000000000002933. Neurology. 2016. PMID: 27527645 Free PMC article.

Cite

Share

5

Cite

Share

Advancing efforts to achieve health equity: equity metrics for health impact assessment practice.

Heller J, Givens ML, Yuen TK, Gould S, Jandu MB, Bourcier E, Choi T. Heller J, et al. Int J Environ Res Public Health. 2014 Oct 24;11(11):11054-64. doi: 10.3390/ijerph111111054. Int J Environ Res Public Health. 2014. PMID: 25347193 Free PMC article.

Cite

Share

6

Cite

Share

Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.

Walsh KS, Janusz J, Wolters PL, Martin S, Klein-Tasman BP, Toledo-Tamula MA, Thompson HL, Payne JM, Hardy KK, de Blank P, Semerjian C, Gray LS, Solomon SE, Ullrich N; REiNS International Collaboration. Walsh KS, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S21-30. doi: 10.1212/WNL.0000000000002928. Neurology. 2016. PMID: 27527646 Free PMC article.

Cite

Share

7

Cite

Share

A simulation-approximation approach to sample size planning for high-dimensional classification studies.

de Valpine P, Bitter HM, Brown MP, Heller J. de Valpine P, et al. Among authors: heller j. Biostatistics. 2009 Jul;10(3):424-35. doi: 10.1093/biostatistics/kxp001. Epub 2009 Feb 21. Biostatistics. 2009. PMID: 19234308 Free PMC article.

Cite

Share

8

Cite

Share

Tetra-O-methyl nordihydroguaiaretic acid inhibits growth and induces death of leukemia cells independent of Cdc2 and survivin.

Mak DH, Schober WD, Chen W, Heller J, Andreeff M, Carter BZ. Mak DH, et al. Among authors: heller j. Leuk Lymphoma. 2007 Apr;48(4):774-85. doi: 10.1080/10428190601186143. Leuk Lymphoma. 2007. PMID: 17454637

Cite

Share

9

Cite

Share

The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration.

Lopez RA, Goodman AB, Rhodes M, Blomberg JA, Heller J. Lopez RA, et al. Among authors: heller j. Anticancer Drugs. 2007 Sep;18(8):933-9. doi: 10.1097/CAD.0b013e32813148e0. Anticancer Drugs. 2007. PMID: 17667599

Cite

Share

10

Cite

Share

Developmental control of blood cell migration by the Drosophila VEGF pathway.

Cho NK, Keyes L, Johnson E, Heller J, Ryner L, Karim F, Krasnow MA. Cho NK, et al. Among authors: heller j. Cell. 2002 Mar 22;108(6):865-76. doi: 10.1016/s0092-8674(02)00676-1. Cell. 2002. PMID: 11955438 Free article.

Cite

Share